Does SELEXIPAG Cause Malignant neoplasm progression? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Malignant neoplasm progression have been filed in association with SELEXIPAG (Selexipag). This represents 0.0% of all adverse event reports for SELEXIPAG.
5
Reports of Malignant neoplasm progression with SELEXIPAG
0.0%
of all SELEXIPAG reports
5
Deaths
1
Hospitalizations
How Dangerous Is Malignant neoplasm progression From SELEXIPAG?
Of the 5 reports, 5 (100.0%) resulted in death, 1 (20.0%) required hospitalization.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SELEXIPAG. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does SELEXIPAG Cause?
Headache (5,693)
Diarrhoea (4,341)
Dyspnoea (3,705)
Nausea (3,392)
Pain in jaw (2,072)
Fatigue (2,009)
Death (1,893)
Pain (1,870)
Pain in extremity (1,797)
Dizziness (1,796)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which SELEXIPAG Alternatives Have Lower Malignant neoplasm progression Risk?
SELEXIPAG vs SELINEXOR
SELEXIPAG vs SELPERCATINIB
SELEXIPAG vs SELUMETINIB
SELEXIPAG vs SEMAGLUTIDE
SELEXIPAG vs SEMUSTINE